Sign Out
Pregnancy: There are no data from the use of Calcipotriol and Betamethasone Dipropionate in pregnant women. In general, the use of topical preparations containing glucocorticoids should be avoided during the first trimester of pregnancy. In particular, treating large areas, prolonged use or occlusive dressing should be avoided during pregnancy. Thus, the clinical indication for treatment with Axtriol-B Gel must be carefully reviewed and the benefits weighed against the risks in pregnant women.
Lactation: Betamethasone passes into breast milk, but risk of an adverse effect on the infant seems unlikely with therapeutic doses. There are no data on the excretion of Calcipotriol in breast milk. Caution should be exercised when prescribing Axtriol-B Gel to women who breastfeed. The patient should be instructed not to use Axtriol-B Gel on the breast when breastfeeding.
Continue with Google